These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 20299674)

  • 1. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.
    Yan SF; Ramasamy R; Schmidt AM
    Circ Res; 2010 Mar; 106(5):842-53. PubMed ID: 20299674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond.
    Ramasamy R; Yan SF; Schmidt AM
    Trends Cardiovasc Med; 2005 Oct; 15(7):237-43. PubMed ID: 16226677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.
    Ramasamy R; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2011 Dec; 1243():88-102. PubMed ID: 22211895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding RAGE, the receptor for advanced glycation end products.
    Bierhaus A; Humpert PM; Morcos M; Wendt T; Chavakis T; Arnold B; Stern DM; Nawroth PP
    J Mol Med (Berl); 2005 Nov; 83(11):876-86. PubMed ID: 16133426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.
    Yan SF; Ramasamy R; Naka Y; Schmidt AM
    Circ Res; 2003 Dec; 93(12):1159-69. PubMed ID: 14670831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
    Schmidt AM; Yan SD; Wautier JL; Stern D
    Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging.
    Yan SF; D'Agati V; Schmidt AM; Ramasamy R
    Curr Mol Med; 2007 Dec; 7(8):699-710. PubMed ID: 18331228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.
    Yan SF; Ramasamy R; Schmidt AM
    Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):285-93. PubMed ID: 18332897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
    Stern DM; Yan SD; Yan SF; Schmidt AM
    Ageing Res Rev; 2002 Feb; 1(1):1-15. PubMed ID: 12039445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAGE: a journey from the complications of diabetes to disorders of the nervous system - striking a fine balance between injury and repair.
    Rong LL; Gooch C; Szabolcs M; Herold KC; Lalla E; Hays AP; Yan SF; Yan SS; Schmidt AM
    Restor Neurol Neurosci; 2005; 23(5-6):355-65. PubMed ID: 16477098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes.
    Lalla E; Lamster IB; Schmidt AM
    Ann Periodontol; 1998 Jul; 3(1):13-9. PubMed ID: 9722686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.
    Yan SF; Ramasamy R; Schmidt AM
    J Mol Med (Berl); 2009 Mar; 87(3):235-47. PubMed ID: 19189073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders.
    Hudson BI; Bucciarelli LG; Wendt T; Sakaguchi T; Lalla E; Qu W; Lu Y; Lee L; Stern DM; Naka Y; Ramasamy R; Yan SD; Yan SF; D'Agati V; Schmidt AM
    Arch Biochem Biophys; 2003 Nov; 419(1):80-8. PubMed ID: 14568011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periodontal disease and the oral-systemic connection: "is it all the RAGE?".
    Katz J; Wallet S; Cha S
    Quintessence Int; 2010 Mar; 41(3):229-37. PubMed ID: 20213024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunobiology of the receptor of advanced glycation end-products: trends and challenges.
    González I; Romero J; Rodríguez BL; Pérez-Castro R; Rojas A
    Immunobiology; 2013 May; 218(5):790-7. PubMed ID: 23182709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities.
    Lalla E; Lamster IB; Stern DM; Schmidt AM
    Ann Periodontol; 2001 Dec; 6(1):113-8. PubMed ID: 11887453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAGE in tissue homeostasis, repair and regeneration.
    Sorci G; Riuzzi F; Giambanco I; Donato R
    Biochim Biophys Acta; 2013 Jan; 1833(1):101-9. PubMed ID: 23103427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAGE: a multi-ligand receptor unveiling novel insights in health and disease.
    Alexiou P; Chatzopoulou M; Pegklidou K; Demopoulos VJ
    Curr Med Chem; 2010; 17(21):2232-52. PubMed ID: 20459381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress.
    Herold K; Moser B; Chen Y; Zeng S; Yan SF; Ramasamy R; Emond J; Clynes R; Schmidt AM
    J Leukoc Biol; 2007 Aug; 82(2):204-12. PubMed ID: 17513693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease.
    Yan SF; Ramasamy R; Schmidt AM
    Expert Rev Mol Med; 2009 Mar; 11():e9. PubMed ID: 19278572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.